Prostate cancer Board decisions

The Board denied service connection for prostate cancer as it is not etiologically related to the Veteran's military service.

The Board has remanded the claims for an initial rating in excess of 70 percent for PTSD, service connection for arthritis, prostate cancer, squamous cell carcinoma of the head and neck, and diabetes. The appellant is also seeking TDIU based on her spouse's service-connected disabilities.

The Board denied the Veteran's claim for an earlier effective date for the 100 percent evaluation assigned for prostate cancer, finding that the earliest indication of the return of the Veteran's prostate cancer was a July 30, 2019 biopsy.

The Board has remanded the claims of service connection for depression with alcoholism and prostate cancer as due to in-service sexually transmitted disease. A new VA examination is required to provide a comprehensive opinion on the relationship between the Veteran's current conditions and his military service.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence of in-service herbicide exposure and no evidence linking the condition to service.

The Board granted service connection for prostate cancer, finding a direct relationship to in-service exposure to contaminated water at Camp Lejeune.

The Veteran's prostate cancer and heart disability are granted service connection based on in-service herbicide agent exposure. The claims for tongue cancer and skin cancer are remanded due to the need to consider PACT Act provisions.

The Veteran's appeal for a compensable initial rating for neoplasms of the male reproductive system, including prostate and testicular cancer, has been dismissed as the Veteran withdrew his appeal in August 2024.

The Veteran withdrew his appeal concerning the issues of service connection for advanced facet disease, increased ratings for prostate cancer residuals, psychiatric disability, and a total disability rating based on individual unemployability due to service-connected disabilities (TDIU).

The Board has remanded the claims for service connection due to herbicide exposure for ischemic heart disease, prostate cancer, and erectile dysfunction. The VA is instructed to contact the U.S. Department of Army to assess if the Veteran was exposed to herbicides at Camp Carroll in Korea.

The Veteran's prostate cancer is granted service connection based on presumed exposure to herbicide agents during service, as supported by lay statements and a VA examination.

The Board denied service connection for benign trivial mitral and tricuspid valve regurgitation, left lung carcinoid tumor, and prostate cancer.,There is no evidence to support the Veteran's claims that these conditions were incurred or aggravated by military service.

The Board has granted service connection for prostate cancer, finding that the Veteran's current condition is related to his in-service exposure to Agent Orange. The decision resolves reasonable doubt in favor of the Veteran.

The Veteran's prostate cancer is remanded for a VA examination to determine if it is related to his service in Camp Lejeune, where he was exposed to contaminated water.

The Board has denied the Veteran's claim for service connection for a right hand disorder, finding no evidence of an in-service injury or disease that led to current symptoms. The claims for compensation under 38 U.S.C. § 1151 for LUTS and IBS with constipation, rectal hyposensitivity, dyssynergic defecation, and anal rectocele are remanded.

The Veteran's appeal is remanded for further development to determine his eligibility for Family Caregiver services under the VA's Program of Comprehensive Assistance for Family Caregivers (PCAFC).

The Veteran's service connection claims for various conditions are remanded due to the need for additional development regarding in-service exposure and continuity of symptoms.

The Veteran's hypertension is granted an initial 10 percent rating, effective August 10, 2022. Service connection for prostate cancer is also granted with a noncompensable rating, effective April 7, 2023.

The Veteran's bilateral flatfoot disability, plantar fasciitis, gastroesophageal reflux disease (GERD), and prostate cancer are all granted as service-connected.

The Board has granted service connection for prostate cancer, urinary incontinence as secondary to prostate cancer, and erectile dysfunction as secondary to prostate cancer. The decision is based on the presumption of exposure to herbicide agents during service at U-Tapao RTAFB, Thailand.